PURPOSE: To investigate the relationship between neuroretinal rim (NRR) differential light absorption (DLA, a measure of spectral absorption properties) and visual field (VF) sensitivity in primary open-angle glaucoma (POAG). METHODS: Patients diagnosed with (n = 22) or suspected of having (n = 7) POAG were imaged with a multispectral system incorporating a modified digital fundus camera, 250-W tungsten-halogen lamp, and fast-tuneable liquid crystal filter. Five images were captured sequentially within 1.0 second at wavelengths selected according to absorption properties of hemoglobin (range, 570-610 nm), and a Beer-Lambert law model was used to produce DLA maps of residual NRR from the images. Patients also underwent VF testing. Differences in NRR DLA in vertically opposing 180° and 45° sectors either side of the horizontal midline were compared with corresponding differences in VF sensitivity on both decibel and linear scales by Spearman's rank correlation. RESULTS: The decibel VF sensitivity scale showed significant relationships between superior-inferior NRR DLA difference and sensitivity differences between corresponding VF areas in 180° NRR sectors (Spearman ρ = 0.68; P < 0.0001), superior-/inferior-temporal 45° NRR sectors (ρ = 0.57; P < 0.002), and superior-/inferior-nasal 45° NRR sectors (ρ = 0.59; P < 0.001). Using the linear VF sensitivity scale significant relationships were found for 180° NRR sectors (ρ = 0.62; P < 0.0002) and superior-inferior-nasal 45° NRR sectors (ρ = 0.53; P < 0.002). No significant difference was found between correlations using the linear or decibel VF sensitivity scales. CONCLUSIONS: Residual NRR DLA is related to VF sensitivity in POAG. Multispectral imaging may provide clinically important information for the assessment and management of POAG.
PURPOSE: To investigate the relationship between neuroretinal rim (NRR) differential light absorption (DLA, a measure of spectral absorption properties) and visual field (VF) sensitivity in primary open-angle glaucoma (POAG). METHODS:Patients diagnosed with (n = 22) or suspected of having (n = 7) POAG were imaged with a multispectral system incorporating a modified digital fundus camera, 250-W tungsten-halogen lamp, and fast-tuneable liquid crystal filter. Five images were captured sequentially within 1.0 second at wavelengths selected according to absorption properties of hemoglobin (range, 570-610 nm), and a Beer-Lambert law model was used to produce DLA maps of residual NRR from the images. Patients also underwent VF testing. Differences in NRR DLA in vertically opposing 180° and 45° sectors either side of the horizontal midline were compared with corresponding differences in VF sensitivity on both decibel and linear scales by Spearman's rank correlation. RESULTS: The decibel VF sensitivity scale showed significant relationships between superior-inferior NRR DLA difference and sensitivity differences between corresponding VF areas in 180° NRR sectors (Spearman ρ = 0.68; P < 0.0001), superior-/inferior-temporal 45° NRR sectors (ρ = 0.57; P < 0.002), and superior-/inferior-nasal 45° NRR sectors (ρ = 0.59; P < 0.001). Using the linear VF sensitivity scale significant relationships were found for 180° NRR sectors (ρ = 0.62; P < 0.0002) and superior-inferior-nasal 45° NRR sectors (ρ = 0.53; P < 0.002). No significant difference was found between correlations using the linear or decibel VF sensitivity scales. CONCLUSIONS: Residual NRR DLA is related to VF sensitivity in POAG. Multispectral imaging may provide clinically important information for the assessment and management of POAG.
Authors: J Berwick; D Johnston; M Jones; J Martindale; P Redgrave; N McLoughlin; I Schiessl; J E W Mayhew Journal: Eur J Neurosci Date: 2005-10 Impact factor: 3.386
Authors: Christopher Bowd; Linda M Zangwill; Felipe A Medeiros; Ivan M Tavares; Esther M Hoffmann; Rupert R Bourne; Pamela A Sample; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2006-07 Impact factor: 4.799
Authors: B Siesky; A Harris; L B Cantor; L Kagemann; Y Weitzman; L McCranor; C Marques; A Werne; E Stefansson Journal: Br J Ophthalmol Date: 2008-04 Impact factor: 4.638
Authors: Julio E Deleón-Ortega; Stella N Arthur; Gerald McGwin; Aiyuan Xie; Blythe E Monheit; Christopher A Girkin Journal: Invest Ophthalmol Vis Sci Date: 2006-08 Impact factor: 4.799
Authors: Sveinn Hakon Hardarson; Alon Harris; Robert Arnar Karlsson; Gisli Hreinn Halldorsson; Larry Kagemann; Ehud Rechtman; Gunnar Már Zoega; Thor Eysteinsson; Jon Atli Benediktsson; Adalbjorn Thorsteinsson; Peter Koch Jensen; James Beach; Einar Stefánsson Journal: Invest Ophthalmol Vis Sci Date: 2006-11 Impact factor: 4.799
Authors: Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti Journal: Bull World Health Organ Date: 2004-12-14 Impact factor: 9.408
Authors: Jeremiah K H Lim; Qiao-Xin Li; Tim Ryan; Phillip Bedggood; Andrew Metha; Algis J Vingrys; Bang V Bui; Christine T O Nguyen Journal: Sci Rep Date: 2021-03-18 Impact factor: 4.379